| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639 [H. O., S. S., T. K., O. K., R. Y., Y. F., Y. N.], Department of Gastroenterological Surgery, Kyoto University Graduate School of Medicine, Kyoto 606-8507 [H. O., T. K., Y. Y.], and Laboratory for Medical Informatics, SNP Research Center, Riken (Institute of Physical and Chemical Research), Tokyo 108-8639 [T. T.], Japan
To disclose detailed genetic mechanisms in hepatocellular carcinoma (HCC) with a view toward development of novel therapeutic targets, we analyzed expression profiles of 20 primary HCCs and their corresponding noncancerous tissues by means of cDNA microarrays consisting of 23,040 genes. Up-regulation of mitosis-promoting genes was observed in the majority of the tumors examined. Some genes showed expression patterns in hepatitis B virus-positive HCCs that were different from those in hepatitis C virus-positive HCCs; most of them encoded enzymes that metabolize carcinogens and/or anticancer agents. Furthermore, we identified a number of genes associated with malignant histological type or invasive phenotype. Accumulation of such data will make it possible to define the nature of individual tumors, to provide clues for identifying new therapeutic targets, and ultimately to optimize treatment of each patient.
This article has been cited by other articles:
![]() |
G. Kurosawa, Y. Akahori, M. Morita, M. Sumitomo, N. Sato, C. Muramatsu, K. Eguchi, K. Matsuda, A. Takasaki, M. Tanaka, et al. Comprehensive screening for antigens overexpressed on carcinomas via isolation of human mAbs that may be therapeutic PNAS, May 20, 2008; 105(20): 7287 - 7292. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Katzenellenbogen, L. Mizrahi, O. Pappo, N. Klopstock, D. Olam, J. Jacob-Hirsch, N. Amariglio, G. Rechavi, E. Domany, E. Galun, et al. Molecular Mechanisms of Liver Carcinogenesis in the Mdr2-Knockout Mice Mol. Cancer Res., November 1, 2007; 5(11): 1159 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Wang, L. L. P.J. Ooi, and K. M. Hui Identification and Validation of a Novel Gene Signature Associated with the Recurrence of Human Hepatocellular Carcinoma Clin. Cancer Res., November 1, 2007; 13(21): 6275 - 6283. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Ho, J.-J. Lin, C.-N. Chen, C.-C. Chen, H. Lee, C.-Y. Yang, Y.-H. Ni, K.-J. Chang, H.-C. Hsu, F.-J. Hsieh, et al. A Gene Expression Profile for Vascular Invasion can Predict the Recurrence After Resection of Hepatocellular Carcinoma: a Microarray Approach Ann. Surg. Oncol., November 1, 2006; 13(11): 1474 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Radhakrishnan, U. G. Bhat, D. E. Hughes, I-C. Wang, R. H. Costa, and A. L. Gartel Identification of a Chemical Inhibitor of the Oncogenic Transcription Factor Forkhead Box M1 Cancer Res., October 1, 2006; 66(19): 9731 - 9735. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ito, S.-i. Funahashi, N. Yamauchi, J. Shibahara, Y. Midorikawa, S. Kawai, Y. Kinoshita, A. Watanabe, Y. Hippo, T. Ohtomo, et al. Identification of ROBO1 as a Novel Hepatocellular Carcinoma Antigen and a Potential Therapeutic and Diagnostic Target. Clin. Cancer Res., June 1, 2006; 12(11): 3257 - 3264. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sato, M. Fukasawa, Y. Yamakawa, T. Natsume, T. Suzuki, I. Shoji, H. Aizaki, T. Miyamura, and M. Nishijima Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein. J. Biochem., May 1, 2006; 139(5): 921 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Tilton, L. G. Gerwick, J. D. Hendricks, C. S. Rosato, G. Corley-Smith, S. A. Givan, G. S. Bailey, C. J. Bayne, and D. E. Williams Use of a Rainbow Trout Oligonucleotide Microarray to Determine Transcriptional Patterns in Aflatoxin B1-Induced Hepatocellular Carcinoma Compared to Adjacent Liver Toxicol. Sci., December 1, 2005; 88(2): 319 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Nambiar, S. R. Boutin, R. Raja, and D. W. Rosenberg Global Gene Expression Profiling: A Complement to Conventional Histopathologic Analysis of Neoplasia Vet. Pathol., November 1, 2005; 42(6): 735 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Yeung, K. P. Lai, H. Y. Chan, N. K. Mak, G. F. Wagner, and C. K. C. Wong Hypoxia-Inducible Factor-1-Mediated Activation of Stanniocalcin-1 in Human Cancer Cells Endocrinology, November 1, 2005; 146(11): 4951 - 4960. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Wonsey and M. T. Follettie Loss of the Forkhead Transcription Factor FoxM1 Causes Centrosome Amplification and Mitotic Catastrophe Cancer Res., June 15, 2005; 65(12): 5181 - 5189. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sanoudou, E. Vafiadaki, D. A. Arvanitis, E. Kranias, and A. Kontrogianni-Konstantopoulos Array lessons from the heart: focus on the genome and transcriptome of cardiomyopathies Physiol Genomics, April 14, 2005; 21(2): 131 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Takata, T. Katagiri, M. Kanehira, T. Tsunoda, T. Shuin, T. Miki, M. Namiki, K. Kohri, Y. Matsushita, T. Fujioka, et al. Predicting Response to Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Neoadjuvant Chemotherapy for Bladder Cancers through Genome-Wide Gene Expression Profiling Clin. Cancer Res., April 1, 2005; 11(7): 2625 - 2636. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Stekel, D. Sarti, V. Trevino, L. Zhang, M. Salmon, C. D. Buckley, M. Stevens, M. J. Pallen, C. Penn, and F. Falciani Analysis of host response to bacterial infection using error model based gene expression microarray experiments Nucleic Acids Res., March 30, 2005; 33(6): e53 - e53. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nishida, S. Mine, T. Utsunomiya, H. Inoue, M. Okamoto, H. Udagawa, T. Hanai, and M. Mori Global Analysis of Altered Gene Expressions during the Process of Esophageal Squamous Cell Carcinogenesis in the Rat: A Study Combined with a Laser Microdissection and a cDNA Microarray Cancer Res., January 15, 2005; 65(2): 401 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Cheung, K. L. Leung, Y. C. Ip, X. Chen, D. Y. Fong, I. O. Ng, S. T. Fan, and S. So Claudin-10 Expression Level is Associated with Recurrence of Primary Hepatocellular Carcinoma Clin. Cancer Res., January 15, 2005; 11(2): 551 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Uchida, T. Tsunoda, S. Wada, Y. Furukawa, Y. Nakamura, and H. Tahara Ring Finger Protein 43 as a New Target for Cancer Immunotherapy Clin. Cancer Res., December 15, 2004; 10(24): 8577 - 8586. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakatsura, H. Komori, T. Kubo, Y. Yoshitake, S. Senju, T. Katagiri, Y. Furukawa, M. Ogawa, Y. Nakamura, and Y. Nishimura Mouse Homologue of a Novel Human Oncofetal Antigen, Glypican-3, Evokes T-Cell-Mediated Tumor Rejection without Autoimmune Reactions in Mice Clin. Cancer Res., December 15, 2004; 10(24): 8630 - 8640. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Breuhahn, S. Vreden, R. Haddad, S. Beckebaum, D. Stippel, P. Flemming, T. Nussbaum, W. H. Caselmann, B. B. Haab, and P. Schirmacher Molecular Profiling of Human Hepatocellular Carcinoma Defines Mutually Exclusive Interferon Regulation and Insulin-Like Growth Factor II Overexpression Cancer Res., September 1, 2004; 64(17): 6058 - 6064. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hippo, K. Watanabe, A. Watanabe, Y. Midorikawa, S. Yamamoto, S. Ihara, S. Tokita, H. Iwanari, Y. Ito, K. Nakano, et al. Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma Cancer Res., April 1, 2004; 64(7): 2418 - 2423. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Kalinichenko, M. L. Major, X. Wang, V. Petrovic, J. Kuechle, H. M. Yoder, M. B. Dennewitz, B. Shin, A. Datta, P. Raychaudhuri, et al. Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor Genes & Dev., April 1, 2004; 18(7): 830 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Kim, S. Oe Lim, J.-S. Kim, Y. H. Ryu, J.-Y. Byeon, H.-J. Kim, Y.-I. Kim, J. S. Heo, Y. M. Park, and G. Jung Comparison of Proteome between Hepatitis B Virus- and Hepatitis C Virus-Associated Hepatocellular Carcinoma Clin. Cancer Res., November 15, 2003; 9(15): 5493 - 5500. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Paradis, I. Bieche, D. Dargere, I. Laurendeau, C. Laurent, P. Bioulac Sage, C. Degott, J. Belghiti, M. Vidaud, and P. Bedossa Molecular Profiling of Hepatocellular Carcinomas (HCC) Using a Large-Scale Real-Time RT-PCR Approach: Determination of a Molecular Diagnostic Index Am. J. Pathol., August 1, 2003; 163(2): 733 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Okabe, S. Satoh, Y. Furukawa, T. Kato, S. Hasegawa, Y. Nakajima, Y. Yamaoka, and Y. Nakamura Involvement of PEG10 in Human Hepatocellular Carcinogenesis through Interaction with SIAH1 Cancer Res., June 15, 2003; 63(12): 3043 - 3048. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kakiuchi, Y. Daigo, T. Tsunoda, S. Yano, S. Sone, and Y. Nakamura Genome-Wide Analysis of Organ-Preferential Metastasis of Human Small Cell Lung Cancer in Mice Mol. Cancer Res., May 1, 2003; 1(7): 485 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Meyer, J.-S. Lee, P. A. Dyck, W.-Q. Cao, M.S. Rao, S. S. Thorgeirsson, and J. K. Reddy Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen Carcinogenesis, May 1, 2003; 24(5): 975 - 984. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Kim and X. W. Wang Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases? Carcinogenesis, March 1, 2003; 24(3): 363 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Anders, L. M. Yerian, M. Tretiakova, J. M. Davison, R. J. Quigg, P. H. Domer, J. Hoberg, and J. Hart cDNA Microarray Analysis of Macroregenerative and Dysplastic Nodules in End-Stage Hepatitis C Virus-Induced Cirrhosis Am. J. Pathol., March 1, 2003; 162(3): 991 - 1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Smith, Z. N. Yue, G. K. Geiss, N. Y. Sadovnikova, V. S. Carter, L. Boix, C. A. Lazaro, G. B. Rosenberg, R. E. Bumgarner, N. Fausto, et al. Identification of Novel Tumor Markers in Hepatitis C Virus-associated Hepatocellular Carcinoma Cancer Res., February 15, 2003; 63(4): 859 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Inoue, A. Matsuyama, K. Mimori, H. Ueo, and M. Mori Prognostic Score of Gastric Cancer Determined by cDNA Microarray Clin. Cancer Res., November 1, 2002; 8(11): 3475 - 3479. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nagayama, T. Katagiri, T. Tsunoda, T. Hosaka, Y. Nakashima, N. Araki, K. Kusuzaki, T. Nakayama, T. Tsuboyama, T. Nakamura, et al. Genome-wide Analysis of Gene Expression in Synovial Sarcomas Using a cDNA Microarray Cancer Res., October 15, 2002; 62(20): 5859 - 5866. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-i. Okutsu, T. Tsunoda, Y. Kaneta, T. Katagiri, O. Kitahara, H. Zembutsu, R. Yanagawa, S. Miyawaki, K. Kuriyama, N. Kubota, et al. Prediction of Chemosensitivity for Patients with Acute Myeloid Leukemia, According to Expression Levels of 28 Genes Selected by Genome-wide Complementary DNA Microarray Analysis, Mol. Cancer Ther., October 1, 2002; 1(12): 1035 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Iizuka, M. Oka, H. Yamada-Okabe, N. Mori, T. Tamesa, T. Okada, N. Takemoto, A. Tangoku, K. Hamada, H. Nakayama, et al. Comparison of Gene Expression Profiles between Hepatitis B Virus- and Hepatitis C Virus-infected Hepatocellular Carcinoma by Oligonucleotide Microarray Data on the Basis of a Supervised Learning Method Cancer Res., July 15, 2002; 62(14): 3939 - 3944. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kuramoto, K. Morimura, S. Yamashita, E. Okochi, N. Watanabe, T. Ohta, M. Ohki, S. Fukushima, T. Sugimura, and T. Ushijima Etiology-specific Gene Expression Profiles in Rat Mammary Carcinomas Cancer Res., July 1, 2002; 62(13): 3592 - 3597. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, S. T. Cheung, S. So, S. T. Fan, C. Barry, J. Higgins, K.-M. Lai, J. Ji, S. Dudoit, I. O.L. Ng, et al. Gene Expression Patterns in Human Liver Cancers Mol. Biol. Cell, June 1, 2002; 13(6): 1929 - 1939. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ramaswamy and T. R. Golub DNA Microarrays in Clinical Oncology J. Clin. Oncol., April 1, 2002; 20(7): 1932 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lee, C. Tarn, W.-H. Wang, S. Chen, R. L. Hullinger, and O. M. Andrisani Hepatitis B Virus X Protein Differentially Regulates Cell Cycle Progression in X-transforming Versus Nontransforming Hepatocyte (AML12) Cell Lines J. Biol. Chem., March 1, 2002; 277(10): 8730 - 8740. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sasaki, S. Ishida, I. Morimoto, T. Yamashita, T. Kojima, C. Kihara, T. Tanaka, K. Imai, Y. Nakamura, and T. Tokino The p53 Family Member Genes Are Involved in the Notch Signal Pathway J. Biol. Chem., January 4, 2002; 277(1): 719 - 724. [Abstract] [Full Text] |
||||
![]() |
Y.-M. Lin, K. Ono, S. Satoh, H. Ishiguro, M. Fujita, N. Miwa, T. Tanaka, T. Tsunoda, K.-C. Yang, Y. Nakamura, et al. Identification of AF17 As a Downstream Gene of the {beta}-catenin/T-Cell Factor Pathway and Its Involvement in Colorectal Carcinogenesis Cancer Res., September 1, 2001; 61(17): 6345 - 6349. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takahashi, D. R. Rhodes, K. A. Furge, H.-o. Kanayama, S. Kagawa, B. B. Haab, and B. T. Teh Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification PNAS, August 1, 2001; (2001) 171209998. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takahashi, D. R. Rhodes, K. A. Furge, H.-o. Kanayama, S. Kagawa, B. B. Haab, and B. T. Teh Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification PNAS, August 14, 2001; 98(17): 9754 - 9759. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |